Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Revenue

Ligand Pharmaceuticals had revenue of $63.69M in the quarter ending June 30, 2026, with 33.73% growth. This brings the company's total for the last twelve months to $290.54M, up 54.89% year-over-year. In the year 2025, Ligand Pharmaceuticals had annual revenue of $268.09M with 60.40% growth. That makes Ligand Pharmaceuticals the 14,759th largest company in the world by revenue and 2,634th in the United States.

• Revenue (ttm): $290.54M
• Revenue Growth: +54.89%
• P/S Ratio: 20.83
• Revenue / Employee: $6,181,745
• Employees: 47
• Market Cap: 6.05B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Revenue from Intangible Royalty Assets 132.53M 49.4%
• Contract Revenue and Income 66.87M 24.9%
• Captisol 40.21M 15.0%
• Income from Financial Royalty Assets 28.47M 10.6%

Fiscal year ended Dec 31, 2025 See the full Ligand Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	268.09M	100.95M	60.40%
Dec 31, 2024	167.13M	35.82M	27.28%
Dec 31, 2023	131.31M	-64.93M	-33.09%
Dec 31, 2022	196.25M	-45.30M	-18.75%
Dec 31, 2021	241.54M	77.98M	47.68%
Dec 31, 2020	163.56M	43.28M	35.98%
Dec 31, 2019	120.28M	-131.17M	-52.17%
Dec 31, 2018	251.45M	110.35M	78.21%
Dec 31, 2017	141.10M	32.13M	29.48%
Dec 31, 2016	108.97M	37.06M	51.53%
Dec 31, 2015	71.91M	7.38M	11.43%
Dec 31, 2014	64.54M	15.57M	31.78%
Dec 31, 2013	48.97M	17.59M	56.02%
Dec 31, 2012	31.39M	1.35M	4.50%
Dec 31, 2011	30.04M	6.50M	27.61%
Dec 31, 2010	23.54M	-15.40M	-39.55%
Dec 31, 2009	38.94M	11.63M	42.56%
Dec 31, 2008	27.32M	14.42M	111.84%
Dec 31, 2007	12.89M	8.92M	224.21%
Dec 31, 2006	3.98M	-6.24M	-61.07%
Dec 31, 2005	10.22M	-	-

Data Source: Fiscal.ai Last updated: Aug 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error